SPOP and endometrial cancer: Recently, whole-exome sequencing studies revealed that genomic mutations in SPOP are frequently present in various tumors, and interestingly, in prostate and endometrial cancer, all mutation regions of SPOP are localized to its MATH domain.[20,21] In addition to mutations, epigenetic silencing also widely contributes to the downregulation of SPOP expression.